Event Brief
Apr 2, 2026 at 3:07 PM ET
Common antidepressant may aid long COVID recovery
By The BriefBrief
A study shows fluvoxamine significantly improves fatigue and quality of life in adults with long COVID.
WHO: Edward Mills
WHAT: Study on fluvoxamine's effects on long COVID
WHEN: Apr 2, 2026 at 2:38 PM ET
WHERE: Canada
WHY: To provide evidence-based treatment options for long COVID patients.
How this brief is built: The BriefBrief correlates multiple sources into one evolving event brief, updated as new facts emerge.
Amazon faces months of repairs after drone strikes
Amazon
May 1, 2026 at 3:23 PM ET
Minnesota bans fake AI nudes; app makers face $500K
Minnesota
May 1, 2026 at 3:23 PM ET
Page 21414 of 21414
Same format. Every time.
Continue reading — sign in or create a free account with
